[go: up one dir, main page]

WO1994011010B1 - Compositions of oak bark extract, related synthetic compositions, and method of using same - Google Patents

Compositions of oak bark extract, related synthetic compositions, and method of using same

Info

Publication number
WO1994011010B1
WO1994011010B1 PCT/US1993/010670 US9310670W WO9411010B1 WO 1994011010 B1 WO1994011010 B1 WO 1994011010B1 US 9310670 W US9310670 W US 9310670W WO 9411010 B1 WO9411010 B1 WO 9411010B1
Authority
WO
WIPO (PCT)
Prior art keywords
parts
ions
composition
oak bark
rubidium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1993/010670
Other languages
French (fr)
Other versions
WO1994011010A3 (en
WO1994011010A2 (en
Filing date
Publication date
Priority to DE69328438T priority Critical patent/DE69328438T2/en
Priority to AT94900557T priority patent/ATE191850T1/en
Priority to CA002148795A priority patent/CA2148795C/en
Priority to DK94900557T priority patent/DK0668769T3/en
Priority to AU55500/94A priority patent/AU700019B2/en
Priority to NZ258019A priority patent/NZ258019A/en
Priority to BR9307401A priority patent/BR9307401A/en
Priority to EP94900557A priority patent/EP0668769B1/en
Priority to JP51222794A priority patent/JP3640215B2/en
Priority to PL93308770A priority patent/PL308770A1/en
Application filed filed Critical
Publication of WO1994011010A2 publication Critical patent/WO1994011010A2/en
Publication of WO1994011010A3 publication Critical patent/WO1994011010A3/en
Publication of WO1994011010B1 publication Critical patent/WO1994011010B1/en
Priority to NO951740A priority patent/NO951740L/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Abstract

Higher concentrations of oak bark ash extract, i.e., greater than 20 % by weight, are useful for the treatment of skin cancers. Lower concentrations of oak bark extract possess additional therapeutic properties not heretofore recognized. For example, preparations containing 40-80 % oak bark extract are useful in the treatment of acute cancerous skin ulcers. In addition, synthetic mixtures containing potassium ions, zinc ions, calcium ions provide many of the same advantageous properties of oak bark extract. The inclusion of rubidium ions and sulfur is also advantageous for some applications.

Claims

AMENDED CLAIMS[received by the International Bureau on 29 September 1994 (29.09.94); original claims 1-21 replaced by amended claims 1-10 (2 pages)]
1. A composition comprising:
10 to 80 parts potassium ions;
0.00001 to 20 parts zinc ions;
0.01 to 10 parts calcium ions; and
1 to 40 parts rubidium ions by weight of inorganic solids, optionally diluted in a pharmaceutically acceptable carrier, with the proviso that the composition is not identical to an aqueous extract of oak bark ash.
2. A composition according to claim 1, comprising 1 to 30 parts rubidium ions.
3. A composition according to claim 1, wherein the carrier is water.
4. A composition according to claim 1, wherein the carrier is a creme base.
5. A method for treating cancerous and precancerous skin lesions comprising applying to the lesion an effective amount of a therapeutic composition comprising
10 to 80 parts potassium ions;
0.00001 to 20 parts zinc ions;
0.01 to 10 parts calcium ions; and
1 to 40 parts rubidium ions by weight of inorganic solids, optionally diluted in a pharmaceutically acceptable carrier, with the proviso that the composition is not identical to an aqueous extract of oak bark ash. - 19 -
6. A method according to claim 5, wherein the composition comprises 1 to 30 parts rubidium ions.
7. A method for treating psoriasis comprising applying to the lesion an effective amount of a therapeutic composition comprising
10 to 80 parts potassium ions;
0.00001 to 20 parts zinc ions;
0.01 to 10 parts calcium ions; and
1 to 40 parts rubidium ions by weight of inorganic solids, optionally diluted in a pharmaceutically acceptable carrier, with the proviso that the composition is not identical to an aqueous extract of oak bark ash.
8. A method according to claim 7, wherein the composition comprises 1 to 30 parts rubidium ions.
9. A method for treating impetigo comprising topically applying an effective amount of a therapeutic composition comprising
10 to 80 parts potassium ions;
0.00001 to 20 parts zinc ions;
0.01 to 10 parts calcium ions; and
1 to 40 parts rubidium ions by weight of inorganic solids, optionally diluted in a pharmaceutically acceptable carrier, with the proviso that the composition is not identical to an aqueous extract of oak bark ash.
10. A method according to claim 9, wherein the composition comprises 1 to 30 parts rubidium ions.
PCT/US1993/010670 1992-11-06 1993-11-04 Compositions of oak bark extract, related synthetic compositions, and method of using same Ceased WO1994011010A2 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP51222794A JP3640215B2 (en) 1992-11-06 1993-11-04 Composition of oak bark extract, related synthetic compositions and methods of using same
CA002148795A CA2148795C (en) 1992-11-06 1993-11-04 Compositions of oak bark extract, related synthetic compositions, and method of using same
DK94900557T DK0668769T3 (en) 1992-11-06 1993-11-04 Oak barley extract-related synthetic compositions and methods for their use
AU55500/94A AU700019B2 (en) 1992-11-06 1993-11-04 Compositions of oak bark extract, related synthetic compositions, and method of using same
NZ258019A NZ258019A (en) 1992-11-06 1993-11-04 Medicinal compositions containing potassium, zinc, calcium and rubidium ions having the same properties as oak bark extract
BR9307401A BR9307401A (en) 1992-11-06 1993-11-04 Oak bark extract compositions related synthetic compositions and method of using the same
EP94900557A EP0668769B1 (en) 1992-11-06 1993-11-04 Synthetic compositions related to oak bark extrakt, and method of using same
DE69328438T DE69328438T2 (en) 1992-11-06 1993-11-04 OAK Bark EXTRACT-RELATED SYNTHETIC PREPARATIONS AND METHOD FOR USE
AT94900557T ATE191850T1 (en) 1992-11-06 1993-11-04 OAK BARK EXTRACT-RELATED SYNTHETIC PREPARATIONS AND METHODS OF USE
PL93308770A PL308770A1 (en) 1992-11-06 1993-11-04 Oak bark extract compositions, similar synthetic composition and method of obtaining them
NO951740A NO951740L (en) 1992-11-06 1995-05-04 Preparations of oak bark extract, related synthetic preparations and methods for using them

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97307192A 1992-11-06 1992-11-06
US07/973,071 1992-11-06

Publications (3)

Publication Number Publication Date
WO1994011010A2 WO1994011010A2 (en) 1994-05-26
WO1994011010A3 WO1994011010A3 (en) 1994-09-15
WO1994011010B1 true WO1994011010B1 (en) 1994-10-27

Family

ID=25520460

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/010670 Ceased WO1994011010A2 (en) 1992-11-06 1993-11-04 Compositions of oak bark extract, related synthetic compositions, and method of using same

Country Status (21)

Country Link
US (1) US6149947A (en)
EP (1) EP0668769B1 (en)
JP (1) JP3640215B2 (en)
AT (1) ATE191850T1 (en)
AU (1) AU700019B2 (en)
BR (1) BR9307401A (en)
CA (1) CA2148795C (en)
CY (1) CY2231B1 (en)
CZ (1) CZ117395A3 (en)
DE (1) DE69328438T2 (en)
DK (1) DK0668769T3 (en)
ES (1) ES2147780T3 (en)
HU (1) HUT73791A (en)
MX (1) MX9306960A (en)
NO (1) NO951740L (en)
NZ (1) NZ258019A (en)
OA (1) OA10153A (en)
PL (1) PL308770A1 (en)
PT (1) PT668769E (en)
WO (1) WO1994011010A2 (en)
ZA (1) ZA938274B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7014870B1 (en) * 1992-11-06 2006-03-21 Greystone Medical Group, Inc. Compositions of oak bark extract related synthetic compositions and method of using same
AUPN104895A0 (en) * 1995-02-10 1995-03-09 Lai, John Methods of and preparations for the treatment of ailments and disorders
US20040037898A1 (en) * 1997-10-08 2004-02-26 Hon David N.S Compositions of oak bark extract, related synthetic compositions and method of using same
RU2125460C1 (en) * 1997-11-17 1999-01-27 Закрытое акционерное общество научно-производственная фирма "Новь" Biostimulating agent
US20050033251A1 (en) * 1998-12-08 2005-02-10 Quick-Med Technologies, Inc. Controlled release of biologically active substances from select substrates
US20040170703A1 (en) * 2001-11-29 2004-09-02 Greystone Medical Group, Inc. Reduction of reactive oxygen species in chronic wound management
WO2003045366A1 (en) * 2001-11-29 2003-06-05 Greystone Medical Group, Inc. Treatment of wounds and compositions employed
US6667026B1 (en) 2002-03-15 2003-12-23 Pocono Falls, Inc. Allergic contact dermatitis treatment and composition therefor
CA2486704A1 (en) * 2002-05-24 2003-12-04 Greystone Medical Group, Inc. Anti-cancer formulation
CN1744819A (en) * 2002-12-23 2006-03-08 格雷斯通医疗集团有限公司 Reduction of reactive oxygen species in chronic wound care
WO2005000328A1 (en) * 2003-06-24 2005-01-06 Zanti Gianfranco Compositions based on plant ash for the treatment of skin diseases
US20060105017A1 (en) * 2004-06-22 2006-05-18 Greystone Medical Group, Inc. Methods for treatment of wounds using time release compositions
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7927614B2 (en) 2006-02-03 2011-04-19 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US8894599B2 (en) 2007-03-15 2014-11-25 Om Kataria Uterine stimulant sticks
EP2211868B1 (en) 2007-10-15 2017-08-02 7 Oaks Pharmaceutical Corporation Silicate containing compositions for the treatment of melanoma
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
US20160184354A1 (en) 2009-01-23 2016-06-30 Jr Chem, Llc Rosacea treatments and kits for performing them
WO2011103158A1 (en) * 2010-02-16 2011-08-25 Michael Darryl Black Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US8828449B2 (en) 2012-01-26 2014-09-09 Libby Robinson Wound dressing composition and method of use
US9351995B1 (en) 2011-04-29 2016-05-31 Red Oax Holdings, LLC Compositions and methods of enhancing wound healing
US20140249462A1 (en) * 2011-07-20 2014-09-04 3M Innovatative Properties Company Dressing with ion-carrying composition
US20140194803A1 (en) * 2011-07-28 2014-07-10 Regents Of The University Of Minnestoa Wound-healing compositions and method of use
US9907702B2 (en) 2011-08-17 2018-03-06 3M Innovative Properties Company Monomer-grafted fibers and uses thereof
GB201402672D0 (en) 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions
WO2016123539A1 (en) 2015-01-29 2016-08-04 Wardell Mark R Wound healing compositions involving medicinal honey, mineral ions, and methylglyoxal, and methods of use
US20220127629A1 (en) * 2019-03-04 2022-04-28 Celloryx AG Chloride-Inducible Prokaryotic Expression System
IT201900018047A1 (en) * 2019-10-07 2021-04-07 Nello Vallicella PROCEDURE FOR THE PREPARATION OF A LIQUID TOPICAL COMPOSITION.
WO2024196897A1 (en) * 2023-03-22 2024-09-26 Courtland Imel Novel methods for increasing healing speed of human and animal wounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US202246A (en) * 1878-04-09 Improvement in medical compounds
US256847A (en) * 1882-04-25 Salve
US37901A (en) * 1863-03-17 Improved liniment
US55911A (en) * 1866-06-26 Improved medical compound
DE819127C (en) * 1949-09-28 1951-10-29 Heinz Dr Bauer Process for the preparation of a therapeutic bath against skin eczema
DE812341C (en) * 1950-03-07 1951-08-27 Penicillin Ges Dauelsberg & Co Process for the preparation of a skin treatment agent
DE833840C (en) * 1950-06-01 1952-03-13 Dr Heinz Bauer Process for the preparation of an ointment against skin eczema
US3928584A (en) * 1969-06-30 1975-12-23 Us Health Education & Welfare Extracts from active tree saps for treating P388 mouse leukemia
US4059695A (en) * 1974-02-14 1977-11-22 Kanari Hirosaki Method for manufacturing a tonic composition for man and other animals
JPS60164467A (en) * 1984-02-07 1985-08-27 Rooman Kogyo:Kk Drink
DE3584837D1 (en) * 1985-10-08 1992-01-16 Psori Med Ag SALT MIXTURE FOR THE TREATMENT OF PSORIASIS AND OTHER SKIN DISEASES.
US4847083A (en) * 1986-04-02 1989-07-11 Dermasciences, Inc. Two-step procedure for indolent wound healing and aqueous medium and topical ointment used in connection therewith
BE1000950A3 (en) * 1987-10-05 1989-05-23 Claude Patricia Cosmetic and pain-relieving compsns. - contg. Dead Sea salt and green clay
AT393221B (en) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh AGENT WITH DESTROYING EFFECT ON MALIGNE TUMORS, METHOD FOR THE PRODUCTION THEREOF AND PREPARATION FOR USE IN THE THERAPY OF CANCER DISEASES
US5080900A (en) * 1990-04-17 1992-01-14 Stanley R Thomas Treatment of skin ulcers with an aqueous extract of oak bark ash

Similar Documents

Publication Publication Date Title
WO1994011010B1 (en) Compositions of oak bark extract, related synthetic compositions, and method of using same
CA2148795A1 (en) Compositions of oak bark extract, related synthetic compositions, and method of using same
BR9306178A (en) Compositions for the treatment of dry and cosmetic skin conditions use of it and process to relieve or improve dry skin conditions acne and dandruff
ES2020011A6 (en) Pharmaceutical compositions comprising catecholic butanes.
CA2072713A1 (en) Cosmetic composition
AU1974888A (en) Glycerol and diglycerol mixtures for skin moisturising
AU5479590A (en) Photoprotection compositions comprising tocopherol sorbate and anti-inflammatory agent
AU3202595A (en) 1,2-substituted imidazolyl compounds for the treatment of inflammation
KR900700128A (en) Trauma Therapy
AU5457390A (en) Photoprotection compositions comprising sorbohydroxamic acid
AU674142B2 (en) Use of cosmetic composition
AU5877486A (en) Composition for the treatment of acne
AU1736588A (en) Anti-inflammatory furanones
CA2130967A1 (en) Long life deodorant composition
AU3650989A (en) Cosmetic composition
PT81516A (en) Process for the preparation of dermotropic cosmetic compositions based on mucosacharides mixed with umbilical chord extract
ZA957506B (en) L-carnite salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
JPS5569595A (en) Novel substance having fibrinolytic activity, remedy for thrombotic embolic disease comprising it, and its preparation
AU2089088A (en) Pharmaceutical composition
WO1994003148A3 (en) Artificial-tan agents for the skin
ES8505919A1 (en) Pomade for psoriasis treatment
IT1186703B (en) Dermatological compsn. e.g. for treatment of psoriasis
UA23915C2 (en) Topical composition with antiparasitic and antibacterial activity
BG98985U (en) AGENT FOR IMPROVING SKIN REGENERATION